Laparoscopic sclerotherapy for ovarian endometriomas during surgery for deep endometriosis: Outcomes of a 134-patient cohort
- PMID: 40332134
- DOI: 10.1002/ijgo.70201
Laparoscopic sclerotherapy for ovarian endometriomas during surgery for deep endometriosis: Outcomes of a 134-patient cohort
Abstract
Objective: To evaluate postoperative fertility outcomes and recurrence rates in patients undergoing laparoscopic ethanol sclerotherapy for endometriomas, combined with the resection of deep endometriosis lesions.
Methods: A retrospective cohort study was conducted at the Franco-European Multidisciplinary Endometriosis Institute (IFEMEndo), Clinique Tivoli-Ducos, Bordeaux, France. The study included 134 patients who underwent laparoscopic surgical resection of deep endometriosis lesions and ethanol sclerotherapy for endometriomas ≥40 mm, between October 2019 and September 2023. The procedure involved aspiration of cyst contents followed by 96% ethanol instillation. The main outcomes measured were fertility rates, endometrioma recurrence, anti-Müllerian hormone (AMH) levels, and postoperative complications.
Results: The mean patient age was 31.8 ± 4.6 years, with 39 (29%) experiencing infertility. Preoperative AMH levels averaged 2.96 ± 2.02 ng/mL and decreased significantly postoperatively (mean difference 1.1 ng/mL, P = 10-8). Severe postoperative complications occurred in 4.5% of patients, none attributed to ethanol sclerotherapy. After surgery, 78 patients expressed a desire to conceive and 45 (57%) achieved pregnancy, with 19 (42%) being spontaneous. The mean time to pregnancy was 13 ± 9 months. Cumulative pregnancy rates were 55.5% at 24 months and 78.8% at 36 months. Predictors of pregnancy included higher preoperative AMH levels (hazard ratio [HR] 1.35, P = 0.008) and absence of prior abdominal surgery (HR 0.32, P = 0.007). Recurrence of endometriomas was observed in 17 (16.5%) patients over a median follow-up of 23 months.
Conclusion: In this cohort of patients treated with laparoscopic ethanol sclerotherapy during resection surgery for deep endometriosis, the procedure was safe, with satisfactory pregnancy and recurrence rates comparable to other ablative techniques.
Keywords: endometrioma; laparoscopy/deep endometriosis; sclerotherapy.
© 2025 International Federation of Gynecology and Obstetrics.
References
REFERENCES
-
- Busacca M, Vignali M. Ovarian endometriosis: from pathogenesis to surgical treatment. Curr Opin Obstet Gynecol. 2003;15:321‐326. doi:10.1097/01.gco.0000084247.09900.4f
-
- Exacoustos C, de Felice G, Pizzo A, et al. Isolated ovarian endometrioma: a history between myth and reality. J Minim Invasive Gynecol. 2018;25:884‐891. doi:10.1016/j.jmig.2017.12.026
-
- Sanchez AM, Viganò P, Somigliana E, Panina‐Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma‐mediated damage to the ovary. Hum Reprod Update. 2014;20:217‐230. doi:10.1093/humupd/dmt053
-
- Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis†. Hum Reprod Open. 2022;2022:hoac009. doi:10.1093/hropen/hoac009
-
- Benaglia L, Somigliana E, Vercellini P, Abbiati A, Ragni G, Fedele L. Endometriotic ovarian cysts negatively affect the rate of spontaneous ovulation. Hum Reprod. 2009;24:2183‐2186. doi:10.1093/humrep/dep202
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical